HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rhona Stein Selected Research

milatuzumab

1/2013Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
4/2009Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines.
9/2007CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
12/2004Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rhona Stein Research Topics

Disease

20Neoplasms (Cancer)
06/2018 - 01/2002
12Lymphoma (Lymphomas)
02/2011 - 12/2003
7Multiple Myeloma
10/2010 - 10/2004
7Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2010 - 04/2004
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2009 - 12/2003
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2013
1Hematologic Neoplasms (Hematological Malignancy)
10/2010
1Leukemia
06/2010
1Hairy Cell Leukemia
06/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2010
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2010
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2010
1Burkitt Lymphoma (Burkitt's Lymphoma)
02/2007
1Autoimmune Diseases (Autoimmune Disease)
02/2007
1Colonic Neoplasms (Colon Cancer)
04/2005
1Residual Neoplasm
04/2005
1Neoplasm Metastasis (Metastasis)
12/2004
1medullary Thyroid cancer
12/2004
1Breast Neoplasms (Breast Cancer)
03/2004
1Thyroid Neoplasms (Thyroid Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

15Monoclonal AntibodiesIBA
02/2011 - 01/2002
6HLA-DR Antigens (HLA-DR)IBA
08/2011 - 07/2005
5Rituximab (Mabthera)FDA Link
06/2010 - 04/2004
5AntigensIBA
09/2007 - 01/2002
4milatuzumabIBA
01/2013 - 12/2004
4veltuzumabIBA
10/2009 - 04/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009 - 07/2005
3Radioisotopes (Radionuclides)IBA
09/2007 - 10/2004
3Pharmaceutical PreparationsIBA
12/2004 - 01/2002
2Immunoconjugates (Immunoconjugate)IBA
06/2018 - 07/2005
2Immunoglobulin G (IgG)IBA
02/2011 - 06/2010
2AntibodiesIBA
10/2010 - 06/2009
2Bispecific AntibodiesIBA
06/2009 - 09/2007
2Complement System Proteins (Complement)IBA
01/2009 - 04/2004
2epratuzumabIBA
02/2007 - 04/2004
2IodineIBA
04/2005 - 03/2004
2Dacarbazine (DIC)FDA LinkGeneric
12/2004 - 01/2002
2chloramine-T (Clorina)IBA
03/2004 - 01/2003
1Surface Antigens (Surface Antigen)IBA
06/2018
1sacituzumab govitecanIBA
06/2018
1Glycoproteins (Glycoprotein)IBA
06/2018
1Irinotecan (Camptosar)FDA LinkGeneric
06/2018
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2011
1IMMU-114IBA
06/2010
1JNK Mitogen-Activated Protein KinasesIBA
06/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2010
1Interferon-alpha2bIBA
10/2009
1Interferon alpha-2 (Roferon-A)FDA Link
10/2009
1Interferon-alpha (Interferon Alfa)IBA
10/2009
1LipidsIBA
06/2009
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2009
1Bortezomib (Velcade)FDA Link
04/2009
1Humanized Monoclonal AntibodiesIBA
10/2008
1HaptensIBA
09/2007
1Ribonucleases (Ribonuclease)IBA
09/2007
1Peptides (Polypeptides)IBA
09/2007
1IsotopesIBA
09/2007
1IMMU-110IBA
07/2005
1labetuzumabIBA
12/2004
1Carcinoembryonic AntigenIBA
12/2004
1ThymidineIBA
10/2004
1Messenger RNA (mRNA)IBA
10/2004
1Proteins (Proteins, Gene)FDA Link
10/2004
1AnthracyclinesIBA
12/2003
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2002
1rofecoxib (Vioxx)FDA Link
04/2002
1Celecoxib (Celebrex)FDA Link
04/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2002

Therapy/Procedure

13Therapeutics
02/2011 - 04/2002
3Immunotherapy
06/2018 - 09/2007
3Radioimmunotherapy
04/2005 - 01/2002
2Drug Therapy (Chemotherapy)
12/2004 - 01/2002
1Combined Modality Therapy
01/2002